Regivell
Brand Name: Regivell
Generic Name: Bupivacaine Hydrochloride in Dextrose
Active
Registration Number
DR-XY44396
Dosage Form
Solution For Injection (Spinal)
Issuance Date
November 29, 2024
Expiry Date
April 13, 2030
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5mg/mL (0.5%w/v)
PackagingUSP Type 1 Glass Ampoule x 4mL (Box of 5's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Local Anesthetic
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Bupivacaine Hydrochloride in DextroseActive
Monograph: bupivacaine hydrochloride in dextrose